In response to RFA: AR-05-005, we propose to create a Center of Research Translation entitled """"""""Center for Lupus Research"""""""". The Center will be focused on the study of Human Lupus Erythematosus. It will incorporate the efforts of immunologists (both basic and translational), and physician-scientists with expertise in the research and care of patients with lupus from several Institutions. The goals of the Center are to understand the role of neutrophils and monocytes in lupus pathogenesis, to determine the checkpoints where mature B cells break tolerance against self, and to develop better markers of disease activity and response to therapy for patients with Systemic and Cutaneous Lupus. Objectives: The Center will establish: i) The role of neutrophils, monocytes and B cells in SLE pathogenesis, ii) The factor(s) responsible for the unabated DC differentiation in SLE, iii) B cell tolerance checkpoints of mature B cells, iv) Markers of disease activity, v) Markers predictive of response to therapy in patients with lupus nephritis, and vi) Markers predictive of systemic evolution of local (cutaneous) disease. Deliverables: i) Extensive microarray database of blood SLE samples and of blood and skin cutaneous lupus samples, ii) Robust, transcriptional and protein-based assays to assess SLE disease activity and to predict response to therapy, iii) Knowledge on the role of monocytes, neutrophils and B cells in SLE pathogenesis, iv) Pre-clinical therapeutic value of TLR7/8/9 inhibitors. Our proposal meets the RFA requirements with regard to: 1) The overarching aim of disease-specific research translation, 2) Inclusion of resources and an administrative structure to facilitate research translation, 3) Inclusion of projects that are translational in nature, directed at elucidating the relevance of basic research to human disease: all 4 main projects involve the study of SLE patient cells and/or tissues. 4) Multi-investigator and Multidisciplinary team;Synergy for the theme: 7) The CORT is focused on one of the diseases in the NIAMS mission: human lupus. 8) There is existing research base supporting each of the projects demonstrated by numerous publications in highly visible journals. 9) All projects include patientoriented research, including a) mechanisms of human disease and/or b) development of new tools to assess disease activity. 10) The CORT Advisory Group represents scientific expertise in SLE and a lay person. An Education Component will establish an annual Symposium and Workshop to educate scientists in the field of lupus research. This component will also maintain a website. Thus, the Center will provide 1) novel markers for disease follow up and response to therapy;and 2) novel molecules relevant for disease pathogenesis and 3) novel therapeutic targets.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center (P50)
Project #
5P50AR054083-05
Application #
7930572
Study Section
Special Emphasis Panel (ZAR1-MLB-G (M1))
Program Officer
Wang, Yan Z
Project Start
2006-08-21
Project End
2011-07-31
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
5
Fiscal Year
2010
Total Cost
$1,033,649
Indirect Cost
Name
Baylor Research Institute
Department
Type
DUNS #
145745022
City
Dallas
State
TX
Country
United States
Zip Code
75204
Cepika, Alma-Martina; Banchereau, Romain; Segura, Elodie et al. (2017) A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis. J Exp Med 214:3449-3466
Banchereau, Romain; Cepika, Alma-Martina; Banchereau, Jacques et al. (2017) Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics. Annu Rev Immunol 35:337-370
Banchereau, Romain; Hong, Seunghee; Cantarel, Brandi et al. (2016) Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell 165:551-65
Caielli, Simone; Athale, Shruti; Domic, Bojana et al. (2016) Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J Exp Med 213:697-713
Rodriguez-Pla, Alicia; Patel, Pinakeen; Maecker, Holden T et al. (2014) IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes. J Immunol 192:5586-98
Joo, Hyemee; Coquery, Christine; Xue, Yaming et al. (2012) Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation. J Exp Med 209:1335-48
Morita, Rimpei; Schmitt, Nathalie; Bentebibel, Salah-Eddine et al. (2011) Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108-21
Garcia-Romo, Gina S; Caielli, Simone; Vega, Barbara et al. (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20
Bentebibel, Salah-Eddine; Schmitt, Nathalie; Banchereau, Jacques et al. (2011) Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc Natl Acad Sci U S A 108:E488-97
Mathian, Alexis; Gallegos, Mike; Pascual, Virginia et al. (2011) Interferon-? induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB├ŚNZW)F1 mice but not in BALB/c mice. Eur J Immunol 41:863-72

Showing the most recent 10 out of 23 publications